BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
196 hedge funds and large institutions have $996M invested in bluebird bio in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
49% less call options, than puts
Call options by funds: $9.13M | Put options by funds: $17.8M
55% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 58
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
196
Holding in Top 10
–
Calls
$9.13M
Puts
$17.8M
Top Buyers
| 1 | +$43.4M | |
| 2 | +$33M | |
| 3 | +$15.3M | |
| 4 |
AC
Armistice Capital
New York
|
+$12.2M |
| 5 |
SC
Sessa Capital
New York
|
+$12.1M |
Top Sellers
| 1 | -$40.1M | |
| 2 | -$37M | |
| 3 | -$18M | |
| 4 |
DM
Deerfield Management
New York
|
-$15.4M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$12.1M |